Abstract
Fabry disease is caused by loss of activity of the lysosomal hydrolase α-galactosidase A (GLA). Premature life-threatening complications in Fabry patients arise from cardiovascular disease, including stroke and myocardial infarction. Exercise training has been shown to improve endothelial dysfunction in various settings including coronary artery disease. However, the effects of exercise training on endothelial dysfunction in Fabry disease have not been investigated. Gla knockout mice were single-housed in a cage equipped with a voluntary wheel (EX) or no wheel (SED) for 12 weeks. Exercised mice ran 10 km/day on average during the voluntary running intervention (VR) period. Despite significantly higher food intake in EX than SED, body weights of EX and SED remained stable during the VR period. After the completion of VR, citrate synthase activity in gastrocnemius muscle was significantly higher in EX than SED. VR resulted in greater phosphorylation of Akt (S473) and AMPK (T172) in the aorta of EX compared to SED measured by western blot. Furthermore, VR significantly enhanced eNOS protein expression and phosphorylation at S1177 by 20% and 50% in the aorta of EX when compared with SED. Similarly, plasma nitrate and nitrite levels were 77% higher in EX than SED. In contrast, measures of anti- and pro-oxidative enzymes (superoxide dismutase and p67phox subunit of NADPH oxidase) and overall oxidative stress (plasma oxidized glutathione) were not different between groups. Although the aortic endothelial relaxation to acetylcholine was slightly increased in EX, it did not reach statistical significance. This study provides the first evidence that VR improves Akt/AMPK/eNOS signaling cascades, but not endothelial function in the aorta of aged Gla deficient mice.
Introduction
Fabry disease is an X-linked lysosomal storage disorder that results from a defective or absent activity of α-galactosidase A (GLA) [1]. The enzymatic defect leads to a progressive accumulation of glycosphingolipids including globotriaosylceramide, galabiosylceramide, and globotriaosylsphingosine. Glycosphingolipid accumulation is observed in a variety of cell types, notably in the endothelium and smooth muscle cells [2, 3]. Early symptoms of Fabry disease in childhood include episodic acute pain and gastrointestinal involvement with abdominal pain, diarrhea, and nausea [3]. However, premature life-threatening complications arise from cardiovascular diseases around the fourth decade of life, and include cerebrovascular events, myocardial infarction, hypertrophic cardiomyopathy, and renal failure [4]. Whereas enzyme replacement therapy (ERT) with recombinant GLA is a long standing approved treatment for Fabry disease, there is only limited evidence that ERT alters the natural course of cardiovascular morbidities in patients with advanced Fabry disease [5].
A mouse model of Fabry disease has been used to explore the vascular pathophysiology in the setting of GLA deficiency. Several inducible models of vasculopathy in these mice have demonstrated accelerated atherosclerosis, oxidant-induced occlusive arterial thrombosis, impaired acetylcholine-induced vascular relaxation, and the presence of endothelial nitric oxide synthase (eNOS) uncoupling [6–9]. A common basis for these experimentally observed abnormalities may be decreased nitric oxide (NO) bioavailability. Exercise has been shown to be one of the most effective non-pharmacological interventions for improving NO bioavailability [10]. During the last two decades, the beneficial effects of exercise on the vascular endothelium have been extensively studied in various aspects including endothelium-dependent vasodilation, anti-inflammation, and anti-atherosclerosis [11–13]. Furthermore, exercise has been demonstrated to improve acetylcholine-mediated coronary blood flow even in the setting of documented coronary artery disease [14, 15], suggesting that the presence of advanced disease does not preclude improvements in endothelial function resulting from exercise. Although exercise intolerance has been reported in patients with Fabry disease previously [16], a more recent study showed that exercise training could improve exercise capacity and well-being of Fabry patients who refrained from physical activity in the past [17]. This suggests that exercise training might be an alternative therapeutic option in Fabry disease. Yet, the benefits of exercise training with respect to vasculopathy in Fabry disease remain unclear.
The purpose of the present study, therefore, was to assess directly the effects of 12 weeks of voluntary wheel exercise training on signaling and functional alterations in the aorta using an established mouse model of Fabry disease. Specifically, we focused on aortic endothelial function, selected enzymes influencing the NO bioavailability in the endothelium (AMPK, Akt, eNOS expression and S1177, superoxide dismutase, and the p67phox subunit of NADPH oxidase), indirect markers of vascular oxidative/nitrosative stress level (3-nitrotyrosine), plasma markers of nitric oxide (nitrate and nitrite), and overall oxidative stress (oxidized glutathione).
Materials and methods
Mice
Gla null mice (129/SvJXC57BL/6J) used in this study were bred from mice originally generated and provided by Drs. Ashok Kulkarni and Roscoe Brady (National Institute of Health, Bethesda, MD) as described previously [18]. These mice were back-crossed a minimum of six generations to the C57BL/6J strain. The animals were maintained on a 12-h light/dark cycle with free access to food and water ad libitum. A week before the voluntary wheel intervention, groups of male mice (8–11 months) with similar average body weight were single-housed and assigned to either a control sedentary (n = 20, SED) or voluntary wheel running group (n = 20, EX). Mice in the EX group were provided with a running wheel (5” diameter x 2” width) equipped with an odometer (Bell dashboard 100-F12) for 12 weeks. Running distance and food intake were monitored daily. Body weight was measured weekly. All animal experiments were conducted according to the protocol, which was approved by the Institutional Animal Care and Use Committee of the University of Michigan.
Tissue harvest
Mice were euthanized with an injection of pentobarbital sodium (66.5 mg/kg ip) at approximately 0900 h. Due to the logistics of the functional studies of the aorta, one mouse from each group was euthanized per day on consecutive days at the end of the 12-week intervention. The remaining mice not used in the functional studies were euthanized at the 12-week intervention time point. Animals in the EX group had access to the voluntary wheel up until the time of tissue collection.
Aortic protein expression
The thoracic aorta was dissected, cleared of surrounding connective tissues in cold physiological salt solution (PSS, mmol/L: 130 NaCl, 4.7 KCl, 1.18 KHPO4, 1.17 MgSO4, 1.6 CaCl2, 14.9 NaHCO3, 5.5 dextrose, and 0.03 EDTA), and frozen in liquid nitrogen. The vessels were pulverized in liquid nitrogen using a pestle. Each powdered sample was lysed with 200 μl RIPA lysis buffer (#R0278, Sigma) with 1X mixture of phosphatase/protease inhibitors (#P2714, P0044, and P5726, Sigma). Homogenates were then incubated on a rotor at 4°C for 1 hr. Cell debris was removed by centrifugation at 10,000 x g for 10 min at 4°C. Quantification of total protein in each aortic lysate sample was determined by a bicinchoninic acid assay with bovine serum albumin as a standard. For measures of aortic protein expression, 15 μg of protein with Laemmli sample buffer were loaded on 4–12% gradient gels, separated by electrophoresis, and transferred onto a nitrocellulose membrane. The membrane was blocked in 5% non-fat dry milk in Tris-buffered saline with 0.1% Tween-20 (TBST) for at least 1 hr at room temperature. After blocking, the membrane was washed with TBST and incubated with primary antibody overnight at 4°C followed by washing with TBST. Primary antibodies used were eNOS (#ab76198, Abcam), phospho-eNOS Ser1177 (#9571, Cell Signaling), Akt (#2938, Cell Signaling), phospho-Akt Ser473 (#4060, Cell Signaling), AMPK (#5831, Cell Signaling), phospho-AMPK Thr172 (#2531, Cell Signaling), 3-nitrotyrosine (#ab7048, Abcam), VASP (#3112, Cell Signaling), phospho-VASP Ser239 (#3114, Cell Signaling), SOD1(#ab13498, Abcam), SOD2 (#ab16956, Abcam), SOD3 (#S4946, Sigma), and p67phox (#610912, BD Bioscience). The membrane was incubated with appropriate secondary antibody. The immunoreactive bands were detected with ECL western blotting substrate (#32106, Thermo Fisher), and quantified by densitometric scanning using ImageJ software.
Citrate synthase activity assay
Gastrocnemius muscles from SED and EX mice were dissected and flash frozen in liquid nitrogen. Frozen muscles were weighed, transferred to pre-chilled glass tissue grinding tubes (Kontes, Vineland, NJ), and homogenized 1:20 (wt:vol) in ice-cold lysis buffer (50mM TRIS-HCl, 1mM EDTA, 0.1% Triton X-100, pH 7.2) using a glass pestle attached to a motorized homogenizer (Caframo, Wiarton, ON). Homogenates were then incubated on a rotor at 4°C for 1 hr. The lysates were centrifuged at 10,000 x g for 10 min at 4°C to remove cell debris. Quantification of total protein in each aortic lysate sample was performed by a bicinchoninic acid assay with bovine serum albumin as a standard. Two micrograms of gastrocnemius homogenate were used. Citrate synthase activity was determined using an assay kit according to the instructions (#701040, Cayman).
Plasma nitric oxide level
Plasma nitric oxide levels were determined by photometric analysis using a nitrate/nitrite assay kit according to the instructions (#780001, Cayman). One hundred microliter of plasma was filtered through a 10 kDa molecular weight cut-off filter by centrifugation at 14,000 x g for 30 min at 4°C in order to reduce background absorbance due to the presence of hemoglobin.
Glutathione measurements
The level of oxidized glutathione (GSSG) was determined using a commercially available glutathione (GSSG/GSH) assay kit (#STA-312, Cell Biolabs). Total glutathione level (oxidized + reduced glutathione) was determined by adding glutathione reductase. GSH level was determined without the enzyme.
Assessment of aortic endothelial function
Following tissue harvesting, the thoracic aortae were dissected and placed in a dissection Petri dish filled with cold PSS. After removing connective tissue, segments (2–3 mm in length) of aorta were mounted on pins in a myograph system (model 610M, Danish Myo Technology, Aarhus, Denmark). Vessels were slowly warmed (37°C) and aerated (95% O2 and 5% CO2) in PSS for 20 min. Rings were set at 700 mg passive tension and equilibrated for 60 min with washing with pre-warmed and aerated PSS every 20 min. Prior to performing concentration response curves, vessels were subjected to osmotically balanced 60 mM potassium physiological salt solution (KPSS, mmol/l: 14.7 NaCl, 100 KCl, 1.18 KHPO4, 1.17 MgSO4, 1.6 CaCl2, 14.9 NaHCO3, 5.5 dextrose, and 0.03 EDTA). After washing, the vessels were contracted with 100 mmol/L KPSS until a plateau was attained, followed by washes. Phenylephrine (PE, 10−9 mol/L to 10−4 mol/L) was added cumulatively to establish a concentration-response curve, in which PE EC80 was calculated for each individual ring. The vessels were contracted with their individual PE EC80 values and allowed to reach a stable plateau. Subsequently, acetylcholine (ACh) or sodium nitroprusside (SNP) was added cumulatively to the chamber to determine endothelium-dependent (ACh) or endothelium-independent (SNP) relaxation. All chemicals used in the vascular reactivity study were purchased from Sigma (St. Louis, MO). The vascular reactivity to ACh or SNP was presented on a percent basis according to the following formula: Relaxation (%) = (TPE80 –Td) / (TPE80) x 100, where TPE80 is the steady-state tension produced after addition of PE EC80, and Td is the steady state tension following addition of vasoactive agent (ACh, SNP). Sensitivity (EC50) was defined as the concentration of the agent that produced 50% of its maximal response. A total of eight mice per group were utilized for these studies.
Statistical analysis
GraphPad Prism software was used for statistical analysis. The data were presented as mean ± standard error of the mean. Results were analyzed using the unpaired t-test for comparison of two groups. For vascular reactivity studies using ACh or SNP, concentration-response data was analyzed using two-way ANOVA (exercise and concentration) to compare the concentration-response curves between the EX and SED groups. Bonferroni’s post hoc test was used to assess differences at individual points on the concentration-response curves if the results of the two-way ANOVA comparison between curves were significantly different. Statistical significance was set at p<0.05.
Results
Overall effects of voluntary wheel running on non-vascular endpoints
The mice in the voluntary running wheel group (EX) ran on average 10 ± 0.75 km/day (Fig 1A). During the first week of the exercise intervention, food intake was not different between the mice in the sedentary control (SED) and EX groups (Fig 1B). In the second week, consistent with the increased running distance, EX mice consumed 24% more food compared to SED mice. Interestingly, body weights were not different at the completion of voluntary wheel running (VR) compared to the beginning of VR in both SED and EX mice (Fig 1C). Despite no changes in total body mass, 12 weeks of VR resulted in a significantly higher heart to body mass ratio and lower gonadal fat to body mass ratio in EX mice compared to those in SED mice (Table 1). The activity of citrate synthase as a marker for mitochondrial content was also measured to confirm an exercise training effect [19, 20]. Consistent with the results in running distance, there was a 49% increase in the citrate synthase activity in gastrocnemius muscle of EX mice compared with SED controls (Fig 2).
Table 1. Summary of parameters of SED and EX mice.
SED | EX | |
---|---|---|
Final body weight (g) | 35.1 ± 0.6 | 34.0 ± 0.6 |
Food intake (g/day) | 5.4 ± 0.1 | 6.9 ± 0.2* |
Heart (mg) | 198.4 ± 5.6 | 225.0 ± 6.2* |
Heart:BW (g/g x 100) | 0.57 ± 0.01 | 0.66 ± 0.01* |
Gonadal fat (mg) | 533.7 ± 46.1 | 277.9 ± 18.7* |
GF:BW (g/g x 100) | 1.50 ± 0.12 | 0.82 ± 0.06* |
Data are shown as mean ± SEM (n = 19 per group).
*p < 0.01 compared to SED mice.
VR increases Akt / AMPK / eNOS signaling pathways in the aorta of EX mice
Exercise has been shown to increase eNOS activity, in part, through shear stress [21]. Akt and AMPK have been proposed to be critical mediators of shear stress-induced eNOS activation [22]. The expression and phosphorylation status of Akt, AMPK, and eNOS were determined to test the hypothesis that VR induced changes in signaling pathways in the aorta. The level of p-AMPK (Thr-172) normalized to GAPDH (arbitrary units; 100 ± 10% vs. 138 ± 13%: SED vs. EX) as well as the ratio of p-AMPK (Thr-172) / t-AMPK (arbitrary units; 100 ± 9% vs. 137 ± 13%: SED vs. EX) were significantly higher in the aorta of EX than SED mice (Fig 3A). A significant increase in the p-Akt (Ser-473) / GAPDH (arbitrary units; 100 ± 25% vs. 159 ± 24%: SED vs. EX) and p-Akt (Ser-473) / t-Akt ratio (arbitrary units; 100 ± 9% vs. 148 ± 17%: SED vs. EX) were also noted in the aorta of EX mice in comparison with SED mice (Fig 3B). It has been shown that phosphorylation of eNOS at Ser1177 is a major downstream target of Akt and AMPK in response to exercise and shear stress [21]. Consistent with the previous finding, we observed a significantly higher levels of p-eNOS (Ser-1177) to GAPDH (arbitrary units; 100 ± 16% vs. 164 ± 21%: SED vs. EX) and p-eNOS (Ser-1177) to total eNOS ratio (arbitrary units; 100 ± 10% vs. 154 ± 12%: SED vs. EX) in the aorta of EX mice when compared to that of SED mice (Fig 3C). In addition, the ratio of eNOS to GAPDH protein expression was significantly elevated (arbitrary units; 100 ± 2% vs. 120 ± 4%: SED vs. EX) in the aorta of EX in comparison with SED mice (Fig 3D). These results suggested that 12 weeks of VR intervention mediated an increase in expression and activity of eNOS and its upstream signaling kinases.
Nitric oxide and oxidative stress level
We previously reported that GLA deficiency results in eNOS uncoupling and reduced NO bioavailability [23]. Citrated plasma was used to determine the effects of VR on NO and oxidative stress levels. VR resulted in a significantly higher level of NO measured by total nitrate and nitrite levels (37.8 ± 2.2 μM vs. 67.2 ± 13.1 μM: SED vs. EX) (Fig 4A), which was in line with the increased total and phospho/total eNOS levels in EX than SED mice. However, the overall oxidative stress level, determined by measurements of GSSG level (0.13 ± 0.03 μM vs. 0.11 ± 0.03 μM: SED vs. EX) as well as GSH/GSSG ratio (arbitrary unit; 1.88 ± 0.29 vs. 2.21 ± 0.24) were not different between groups following 12 weeks of VR (Fig 4B). We and others have observed increased levels of oxidative/nitrosative stress in tissues of patients with Fabry disease and GLA-deficient mice [24–26]. Thoracic aortae were used to determine the effects of VR on 3-nitrotyrosine (NT) abundance, a cellular marker of peroxynitrite formation, therefore vascular oxidative/nitrosative stress [27]. In this study, VR did not alter the level of NT in the aortic tissue (Fig 5A), suggesting the balance between NO and superoxide did not change significantly by VR. NO level in response to exercise was next determined in the aorta. Soluble guanylate cyclase is the major physiological receptor for NO and catalyzes the synthesis of intracellular cGMP level [28]. Protein kinase G is activated by cGMP and preferentially phosphorylates vasodilator-stimulated phosphoprotein (VASP) at Ser-239 [29, 30]. Therefore, VASP is a common marker used for monitoring NO-mediated signaling [30]. However, we observed no changes in both p-VASP (Ser 239) to GAPDH and p-VASP (Ser 239) to t-VASP ratio in response to 12 weeks of VR (Fig 5B). In addition, VR had no effect on the protein expression of Mn-, CuZn-, and ec-SOD in the aortae of EX compared to SED mice (Fig 6A–6C). Finally, we determined the effect of VR on NADPH oxidase, a prominent source of vascular-derived reactive oxygen species, in the aorta [31]. p67phox is one of the subunits of NADPH oxidase, and has been found to be reduced in aorta of mice following VR training [12]. In the present study, VR did not alter p67phox subunit protein expression in EX mice compared to SED (Fig 6D).
Endothelial function
The vascular contraction mediated by 100 mmol/L KPSS was equivalent in aortae from SED and EX mice (1351.81 ± 117.09 mg vs. 1511.36 ± 105.54 mg, n = 8/group, p>0.05). Phenylephrine (PE) caused a concentration-dependent contraction in isolated aortic rings from both SED and EX mice (Fig 7A). The PE-induced contractions were equivalent in aortae from SED and EX mice as demonstrated by similar log EC50 values (-6.58 ± 0.01 vs. -6.63 ± 0.02, p>0.05) as well as equivalent Emax values (140.83 ± 4.71% vs. 140.60 ± 10.01%, p>0.05). Based on the PE-induced contraction response, PE EC80 was calculated for each aortic ring. Receptor-mediated endothelium-dependent relaxation to acetylcholine (ACh) was examined in aortic rings from SED and EX mice. The vessels from SED and EX mice were relaxed in response to ACh in a concentration-dependent manner (Fig 7B). Both the maximal relaxation elicited by ACh (36.21 ± 7.88% vs. 44.0 ± 7.04%, p>0.05) and log EC50 values (-6.73 ± 0.14 vs. -6.78 ± 0.12, p>0.05) did not differ between the groups. Sodium nitroprusside (SNP) induced a concentration-dependent, endothelium-independent relaxation in isolated aortae from SED and EX mice (Fig 7C). SNP-mediated vasodilation was greater in the aortic rings from both SED and EX mice (67.89 ± 7.48% vs. 74.75 ± 6.05%) than the endothelium-dependent dilation to ACh (Fig 7C), suggesting the low magnitude of relaxation to ACh was not due to changes in the sensitivity of vascular smooth muscle to NO.
Discussion
Previous research regarding Fabry disease has focused on the pathophysiologic mechanisms using both patients and mouse models [6–8, 32–34]. However, few studies have investigated the potential effects of exercise training on endothelial dysfunction in Fabry disease [17]. In this study, we examined whether 12 weeks of VR intervention could improve endothelial dysfunction in the presence of eNOS uncoupling in a mouse model of Fabry disease. Our results indicate that in aged mice with Fabry disease, VR (a) induced exercise training adaptations, (b) increased Akt/AMPK/eNOS signaling pathways in the aorta, (c) increased plasma NO levels, but (d) did not improve endothelial dysfunction and systemic markers of oxidative stress in the aorta.
Our finding that VR induced training adaptations in tissues was supported by an increase in heart size and skeletal muscle citrate synthase activity. After 12 weeks of VR, a heart to total body mass ratio was higher in EX compared to SED mice. In addition, the magnitude of the increase in citrate synthase activity observed in EX compared to SED mice was comparable with a previous study examining the skeletal muscle of wild-type C57BL/6J mice following voluntary wheel exercise [35].
EX mice had 54% and 20% higher levels of aortic Ser1177 phosphorylation and protein expression of eNOS, respectively, compared to SED mice. One possible mechanism by which VR augmented eNOS activity as well as protein expression is through an activation of upstream kinases of eNOS by an increase in shear stress during exercise. Several lines of evidence have demonstrated that eNOS mRNA and protein expression are increased in endothelial cells exposed to shear stress [36, 37], in isolated coronary arterioles subjected to elevated intraluminal flow [38, 39], and in the aorta from exercise trained mice [37, 40–42] and rats [43]. In a previous study, shear stress increased eNOS activity, measured by NO production and phosphorylation of eNOS at S1177, via PI(3)K/Akt-dependent pathway in HUVEC cells, which was prevented by wortmannin and in cells transfected with dominant-negative Akt mutant [44]. Zhang et al. showed that arterial p-eNOS S617, which is activated by Akt alone, and p-eNOS S1177, which is activated by both Akt and AMPK, were increased in response to treadmill-running in mice [21]. In the same study, intraperitoneal administration of wortmannin before treadmill running revealed either Akt or AMPK alone might be sufficient to activate p-eNOS S1177 during exercise. As such, we determined activation status of Akt and AMPK in the aorta in response to VR in this study. In keeping with the previous findings, we observed significantly elevated levels of phospho -Akt (S473), -AMPK (T172), and -eNOS (S1177) in the aorta as well as higher plasma NO level in EX as compared to SED mice.
We have previously published that endothelial dysfunction in the aorta is evident in 3–5 month-old GLA deficient compared to WT mice, characterized by decreased maximal vasodilation to ACh in the aorta (Emax: ~60%) [8]. In the present study, the Emax to ACh in GLA deficient mice at 11–13 months was approximately 40%. Another group reported 25% of Emax to ACh in the same mice at 19 months [45]. These results are consistent with a progressive decline in endothelial function in Fabry disease. Indeed, endothelial dysfunction in the mesenteric artery and accelerated oxidant-induced thrombosis in the setting of GLA deficiency in other studies were all shown to be age-dependent [7, 9]. A previous study by Durrant el al. showed that carotid artery vasodilatation to ACh was improved in older mice of an aging model subjected to 10–14 weeks of voluntary running compared to their age-matched sedentary counterparts [12]. On the other hand, some studies have reported that exercise did not improve endothelial function and/or arterial stiffness despite significant improvement in VO2 peak or p-eNOS S1177 [46, 47].
In this study, despite the documented response to training adaptation, VR did not improve endothelial relaxation in the aged Fabry mice. One possible reason might be the rapid inactivation of NO by reactive oxygen species (ROS). Indeed, the dose-dependent Gb3 accumulation in cultured vascular endothelial cells resulted in increased intracellular ROS [34]. In the presence of elevated ROS, NO binds to superoxide to form peroxynitrite, a powerful oxidizing intermediate [48]. NT has been used as a specific marker of the presence of reactive oxygen/nitrogen species [12, 49]. In a previous study, an age-related increase in NT in the aorta of older mice of an aging model was attenuated by VR with a corresponding increase in SOD and decreased NADPH oxidase activity [12]. Although we observed that plasma NO was significantly increased, the overall pattern of oxidative stress levels did not change following VR in the current study. Furthermore, the ratio of phospho to total VASP and the expression of SODs and p67phox, an important regulatory subunit of NADPH oxidase, did not differ significantly between EX and SED mice, suggesting that there were no changes in the balance between NO availability and oxidative/nitrosative stress level.
A second potential explanation for the lack of benefit in VR may be the possible presence of other sources of oxidants. For example, H2O2 has been observed to induce protein kinase G dimerization and vasorelaxation, which was associated with phosphorylation of VASP at Ser239 [50]. In addition, we have previously observed a 6-fold higher level of aortic 3-nitrotyrosine in Gla null mice at 8 months compared with age-matched wild-type mice [25]. Moreover, inducible NOS expression was more than 2 fold higher in the aorta obtained from 12-month-old Gla deficient mice than their wild-type counterpart [6]. In a recent study, Silva et al. showed that 8 weeks of treadmill exercise training resulted in attenuated iNOS and increased phospho- and total eNOS expressions in the mouse aorta [51]. Therefore, it is possible that other sources of oxidants may have been altered following VR, resulting in no difference in the overall expression of NT as well as phosphorylation of VASP.
A third potential reason for the lack of improvement in endothelial function in the aorta might be advanced morphological alterations of the smooth muscle cells and extracellular matrix that preceded the VR intervention. The aortae from GLA deficient mice displayed less sensitive endothelium-independent relaxation with an NO donor compared to wild type mice, suggesting alterations in vascular smooth muscle cells (SMC) [8]. Heare et al. reported that aortic wall thickness of Gla-deficient mice was significantly increased with high Gb3 storage level in endothelium and vascular SMC compared with wild type mice [45]. Progressive thickening of the intima-media layers of radial arteries was also observed in patients with Fabry disease [52]. One hypothesis is that accumulation of lyso-Gb3 (globotriaosylsphingosine) in the SMC promotes SMC proliferation resulting in increased intima-media thickness in the setting of Fabry disease [53]. Gb3 accumulation in the endothelial cells has also been reported to increase ROS and cellular adhesion molecules [34]. Often, these pathological conditions are associated with inflammation, hypertrophy, apoptosis, and replacement fibrosis in older patients with Fabry disease [54, 55]. Fabry patients without myocardial fibrosis, compared to those with myocardial fibrosis, showed better outcomes regarding left ventricular mass, improved myocardial function, and a higher exercise capacity during 3 years of enzyme replacement therapy [56]. Thus, VR may not be able to reverse the age-related alterations that have accumulated before the initiation of the intervention in Fabry disease. Taken together, these data indicate that our exercise intervention does not reverse endothelial dysfunction and oxidative stress level in these aged GLA-deficient mice.
Several limitations exist in our study. First, age-matched wild-type mice were not included for a direct comparison of the measurements with GLA-deficient mice. However, we and others have previously demonstrated endothelial dysfunction in younger and older mice with Fabry disease compared to age-matched wild-type mice [8, 9, 45]. In addition, the primary goal of the present study was to gain initial insight into the effects of exercise on endothelial dysfunction and changes in signaling pathways in aged mice with Fabry disease. Finally, we assessed the levels of signaling kinases in aortic homogenates rather than in the aortic endothelial cells alone. However, a recent study, using phospho-protein-specific antibodies with immunohistochemistry analysis, demonstrated that exercise induced an activation of AMPK with concurrent elevation of p-eNOS S1177 in the endothelial cells to a much greater extent than those in the smooth muscle cells in the aorta of mice [57]. Although our study bears some limitations, this is the first study to evaluate the influence of voluntary running on endothelial function in a mouse model of Fabry disease.
In conclusion, VR significantly improved Akt/AMPK/eNOS signaling pathways without improvement of the severe endothelial dysfunction evident in the aorta of aged mice with Fabry disease. This finding may have relevance to the clinical studies of Fabry disease as well. Emerging clinical data evaluating the effectiveness of long-term enzyme replacement therapy indicated that this therapy does not prevent the occurrence of new cardiovascular complications in Fabry patients with more advanced disease [58]. Furthermore, another recent study demonstrated that Fabry patients with no detectable fibrosis and mild hypertrophy, compared to those with myocardial fibrosis, showed better outcomes regarding left ventricular mass, improved myocardial function, and a higher exercise capacity during 3 years of enzyme replacement therapy [56]. Therefore, evidence is accumulating that early intervention may have more beneficial effects on these patients. Similarly, the findings of this study raise a primary question of whether exercise might suppress the progression of endothelial dysfunction in this setting if started earlier in this disease process. Future studies examining the effects of exercise in younger age or as an adjuvant treatment with enzyme replacement therapy will further our understanding of the effects of exercise as a potential strategy for preventive and therapeutic interventions for vasculopathy in Fabry disease.
Data Availability
Our data has been deposited in the Figshare public repository. The data can be accessed by the url https://doi.org/10.6084/m9.figshare.7695857.v3. These data constitute our "minimal data set" defined as the data set was used to reach the conclusions drawn in the manuscript with related metadata and methods, and any additional data required to replicate the reported study findings in their entirety. This includes the values behind the means, standard deviations and other measures reported.
Funding Statement
This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant RO1 DK 055823 (https://www.niddk.nih.gov/) to JAS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramide trihexosidase deficiency. N Engl J Med. 1967;276(21):1163–7. 10.1056/NEJM196705252762101 [DOI] [PubMed] [Google Scholar]
- 2.Linhart A. The heart in Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford2006. [PubMed] [Google Scholar]
- 3.Germain DP. Fabry disease. Orphanet journal of rare diseases. 2010;5:30 10.1186/1750-1172-5-30 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Eng CM, Fletcher J, Wilcox WR, Waldek S, Scott CR, Sillence DO, et al. Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. Journal of inherited metabolic disease. 2007;30(2):184–92. 10.1007/s10545-007-0521-2 [DOI] [PubMed] [Google Scholar]
- 5.El Dib RP, Nascimento P, Pastores GM. Enzyme replacement therapy for Anderson-Fabry disease. The Cochrane database of systematic reviews. 2013;2:CD006663. [DOI] [PubMed] [Google Scholar]
- 6.Bodary PF, Shen Y, Vargas FB, Bi X, Ostenso KA, Gu S, et al. Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency. Circulation. 2005;111(5):629–32. 10.1161/01.CIR.0000154550.15963.80 [DOI] [PubMed] [Google Scholar]
- 7.Eitzman DT, Bodary PF, Shen Y, Khairallah CG, Wild SR, Abe A, et al. Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis. J Am Soc Nephrol. 2003;14(2):298–302. [DOI] [PubMed] [Google Scholar]
- 8.Park JL, Whitesall SE, D'Alecy LG, Shu L, Shayman JA. Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect. Clin Exp Pharmacol Physiol. 2008;35(10):1156–63. 10.1111/j.1440-1681.2008.04984.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kang JJ, Shu L, Park JL, Shayman JA, Bodary PF. Endothelial nitric oxide synthase uncoupling and microvascular dysfunction in the mesentery of mice deficient in alpha-galactosidase A. American journal of physiology Gastrointestinal and liver physiology. 2014;306(2):G140–6. 10.1152/ajpgi.00185.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.McAllister RM, Laughlin MH. Vascular nitric oxide: effects of physical activity, importance for health. Essays in biochemistry. 2006;42:119–31. 10.1042/bse0420119 [DOI] [PubMed] [Google Scholar]
- 11.Seals DR, Desouza CA, Donato AJ, Tanaka H. Habitual exercise and arterial aging. Journal of applied physiology. 2008;105(4):1323–32. 10.1152/japplphysiol.90553.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Durrant JR, Seals DR, Connell ML, Russell MJ, Lawson BR, Folian BJ, et al. Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase. The Journal of physiology. 2009;587(Pt 13):3271–85. 10.1113/jphysiol.2009.169771 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bowles DK, Laughlin MH. Mechanism of beneficial effects of physical activity on atherosclerosis and coronary heart disease. Journal of applied physiology. 2011;111(1):308–10. 10.1152/japplphysiol.00634.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003;107(25):3152–8. 10.1161/01.CIR.0000074229.93804.5C [DOI] [PubMed] [Google Scholar]
- 15.Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;342(7):454–60. 10.1056/NEJM200002173420702 [DOI] [PubMed] [Google Scholar]
- 16.Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genetics in medicine: official journal of the American College of Medical Genetics. 2006;8(9):539–48. [DOI] [PubMed] [Google Scholar]
- 17.Schmitz B, Thorwesten L, Lenders M, Duning T, Stypmann J, Brand E, et al. Physical Exercise in Patients with Fabry Disease—a Pilot Study. International journal of sports medicine. 2016;37(13):1066–72. 10.1055/s-0042-110205 [DOI] [PubMed] [Google Scholar]
- 18.Ohshima T, Murray GJ, Swaim WD, Longenecker G, Quirk JM, Cardarelli CO, et al. alpha-Galactosidase A deficient mice: a model of Fabry disease. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(6):2540–4. 10.1073/pnas.94.6.2540 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lopez-Lluch G, Hunt N, Jones B, Zhu M, Jamieson H, Hilmer S, et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(6):1768–73. 10.1073/pnas.0510452103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Konopka AR, Suer MK, Wolff CA, Harber MP. Markers of human skeletal muscle mitochondrial biogenesis and quality control: effects of age and aerobic exercise training. The journals of gerontology Series A, Biological sciences and medical sciences. 2014;69(4):371–8. 10.1093/gerona/glt107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zhang QJ, McMillin SL, Tanner JM, Palionyte M, Abel ED, Symons JD. Endothelial nitric oxide synthase phosphorylation in treadmill-running mice: role of vascular signalling kinases. The Journal of physiology. 2009;587(Pt 15):3911–20. 10.1113/jphysiol.2009.172916 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. American journal of physiology Cell physiology. 2003;285(3):C499–508. 10.1152/ajpcell.00122.2003 [DOI] [PubMed] [Google Scholar]
- 23.Shu L, Park JL, Byun J, Pennathur S, Kollmeyer J, Shayman JA. Decreased nitric oxide bioavailability in a mouse model of Fabry disease. J Am Soc Nephrol. 2009;20(9):1975–85. 10.1681/ASN.2008111190 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Moore DF, Scott LT, Gladwin MT, Altarescu G, Kaneski C, Suzuki K, et al. Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation. 2001;104(13):1506–12. [DOI] [PubMed] [Google Scholar]
- 25.Shu L, Vivekanandan-Giri A, Pennathur S, Smid BE, Aerts JM, Hollak CE, et al. Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease. Kidney Int. 2014;86(1):58–66. 10.1038/ki.2013.520 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Chimenti C, Scopelliti F, Vulpis E, Tafani M, Villanova L, Verardo R, et al. Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy. Human pathology. 2015;46(11):1760–8. 10.1016/j.humpath.2015.07.017 [DOI] [PubMed] [Google Scholar]
- 27.Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE, et al. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circulation research. 2007;100(11):1659–66. 10.1161/01.RES.0000269183.13937.e8 [DOI] [PubMed] [Google Scholar]
- 28.Bellamy TC, Garthwaite J. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells. British journal of pharmacology. 2002;136(1):95–103. 10.1038/sj.bjp.0704687 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Francis SH, Busch JL, Corbin JD, Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacological reviews. 2010;62(3):525–63. 10.1124/pr.110.002907 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Oelze M, Mollnau H, Hoffmann N, Warnholtz A, Bodenschatz M, Smolenski A, et al. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circulation research. 2000;87(11):999–1005. [DOI] [PubMed] [Google Scholar]
- 31.Frey RS, Ushio-Fukai M, Malik AB. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxidants & redox signaling. 2009;11(4):791–810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Moore DF, Kaneski CR, Askari H, Schiffmann R. The cerebral vasculopathy of Fabry disease. Journal of the neurological sciences. 2007;257(1–2):258–63. 10.1016/j.jns.2007.01.053 [DOI] [PubMed] [Google Scholar]
- 33.Moore DF, Ye F, Brennan ML, Gupta S, Barshop BA, Steiner RD, et al. Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study. J Magn Reson Imaging. 2004;20(4):674–83. 10.1002/jmri.20162 [DOI] [PubMed] [Google Scholar]
- 34.Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, et al. Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Molecular genetics and metabolism. 2008;95(3):163–8. 10.1016/j.ymgme.2008.06.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Fentz J, Kjobsted R, Kristensen CM, Hingst JR, Birk JB, Gudiksen A, et al. AMPKalpha is essential for acute exercise-induced gene responses but not for exercise training-induced adaptations in mouse skeletal muscle. American journal of physiology Endocrinology and metabolism. 2015;309(11):E900–14. 10.1152/ajpendo.00157.2015 [DOI] [PubMed] [Google Scholar]
- 36.Davis ME, Cai H, Drummond GR, Harrison DG. Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circulation research. 2001;89(11):1073–80. [DOI] [PubMed] [Google Scholar]
- 37.Davis ME, Cai H, McCann L, Fukai T, Harrison DG. Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training. American journal of physiology Heart and circulatory physiology. 2003;284(4):H1449–53. 10.1152/ajpheart.00918.2002 [DOI] [PubMed] [Google Scholar]
- 38.Woodman CR, Muller JM, Laughlin MH, Price EM. Induction of nitric oxide synthase mRNA in coronary resistance arteries isolated from exercise-trained pigs. The American journal of physiology. 1997;273(6 Pt 2):H2575–9. 10.1152/ajpheart.1997.273.6.H2575 [DOI] [PubMed] [Google Scholar]
- 39.Woodman CR, Muller JM, Rush JW, Laughlin MH, Price EM. Flow regulation of ecNOS and Cu/Zn SOD mRNA expression in porcine coronary arterioles. The American journal of physiology. 1999;276(3 Pt 2):H1058–63. 10.1152/ajpheart.1999.276.3.H1058 [DOI] [PubMed] [Google Scholar]
- 40.Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. The Journal of clinical investigation. 2000;105(11):1631–9. 10.1172/JCI9551 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kojda G, Cheng YC, Burchfield J, Harrison DG. Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation. 2001;103(23):2839–44. [DOI] [PubMed] [Google Scholar]
- 42.Lauer N, Suvorava T, Ruther U, Jacob R, Meyer W, Harrison DG, et al. Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase. Cardiovascular research. 2005;65(1):254–62. 10.1016/j.cardiores.2004.09.010 [DOI] [PubMed] [Google Scholar]
- 43.Barbosa VA, Luciano TF, Marques SO, Vitto MF, Souza DR, Silva LA, et al. Acute exercise induce endothelial nitric oxide synthase phosphorylation via Akt and AMP-activated protein kinase in aorta of rats: Role of reactive oxygen species. International journal of cardiology. 2013;167(6):2983–8. 10.1016/j.ijcard.2012.08.050 [DOI] [PubMed] [Google Scholar]
- 44.Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399(6736):601–5. 10.1038/21224 [DOI] [PubMed] [Google Scholar]
- 45.Heare T, Alp NJ, Priestman DA, Kulkarni AB, Qasba P, Butters TD, et al. Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment. Journal of inherited metabolic disease. 2007;30(1):79–87. 10.1007/s10545-006-0473-y [DOI] [PubMed] [Google Scholar]
- 46.Kitzman DW, Brubaker PH, Herrington DM, Morgan TM, Stewart KP, Hundley WG, et al. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Journal of the American College of Cardiology. 2013;62(7):584–92. 10.1016/j.jacc.2013.04.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Steppan J, Sikka G, Jandu S, Barodka V, Halushka MK, Flavahan NA, et al. Exercise, vascular stiffness, and tissue transglutaminase. Journal of the American Heart Association. 2014;3(2):e000599 10.1161/JAHA.113.000599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Archiv: European journal of physiology. 2010;459(6):923–39. 10.1007/s00424-010-0808-2 [DOI] [PubMed] [Google Scholar]
- 49.Heinecke JW. Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress. Free radical biology & medicine. 2002;32(11):1090–101. [DOI] [PubMed] [Google Scholar]
- 50.Neo BH, Kandhi S, Wolin MS. Roles for soluble guanylate cyclase and a thiol oxidation-elicited subunit dimerization of protein kinase G in pulmonary artery relaxation to hydrogen peroxide. American journal of physiology Heart and circulatory physiology. 2010;299(4):H1235–41. 10.1152/ajpheart.00513.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Silva JF, Correa IC, Diniz TF, Lima PM, Santos RL, Cortes SF, et al. Obesity, Inflammation, and Exercise Training: Relative Contribution of iNOS and eNOS in the Modulation of Vascular Function in the Mouse Aorta. Front Physiol. 2016;7:386 10.3389/fphys.2016.00386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Boutouyrie P, Laurent S, Laloux B, Lidove O, Grunfeld JP, Germain DP. Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. Journal of medical genetics. 2001;38(9):629–31. 10.1136/jmg.38.9.629 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(8):2812–7. 10.1073/pnas.0712309105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Weidemann F, Breunig F, Beer M, Sandstede J, Stork S, Voelker W, et al. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. European heart journal. 2005;26(12):1221–7. 10.1093/eurheartj/ehi143 [DOI] [PubMed] [Google Scholar]
- 55.Sheppard MN, Cane P, Florio R, Kavantzas N, Close L, Shah J, et al. A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy. Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology. 2010;19(5):293–301. [DOI] [PubMed] [Google Scholar]
- 56.Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Stork S, et al. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. 2009;119(4):524–9. 10.1161/CIRCULATIONAHA.108.794529 [DOI] [PubMed] [Google Scholar]
- 57.Cacicedo JM, Gauthier MS, Lebrasseur NK, Jasuja R, Ruderman NB, Ido Y. Acute exercise activates AMPK and eNOS in the mouse aorta. American journal of physiology Heart and circulatory physiology. 2011;301(4):H1255–65. 10.1152/ajpheart.01279.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Rombach SM, Twickler TB, Aerts JM, Linthorst GE, Wijburg FA, Hollak CE. Vasculopathy in patients with Fabry disease: current controversies and research directions. Molecular genetics and metabolism. 2010;99(2):99–108. 10.1016/j.ymgme.2009.10.004 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Our data has been deposited in the Figshare public repository. The data can be accessed by the url https://doi.org/10.6084/m9.figshare.7695857.v3. These data constitute our "minimal data set" defined as the data set was used to reach the conclusions drawn in the manuscript with related metadata and methods, and any additional data required to replicate the reported study findings in their entirety. This includes the values behind the means, standard deviations and other measures reported.